Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Immunotherapy in Melanoma

Breast Cancer

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Immunotherapy in Melanoma

Treatment-Related Dermatologic AEs in Melanoma Require Careful Management

Tracey Liebman, MD, discusses the identification and management of treatment-related dermatologic AEs in patients with melanoma.
Read More >>

Targeting the Hedgehog Pathway Holds Promises and Pitfalls

Optimal AE Management Required With Immunotherapy in Melanoma

Guiding Treatment Decisions in Newly Diagnosed Metastatic Melanoma

Biomarker Hunt Finds Potential With ctDNA in Melanoma

Adjuvant Therapy Transforms Treatment in Advanced Melanoma

View More Stories >>

View Conference Coverage

2020 SGO Winter Meeting

2020 Gastrointestinal Cancers Symposium

2019 San Antonio Breast Cancer Symposium

2019 ASH Annual Meeting

2019 International Congress of the Society for Melanoma Research

Dr. Sznol on Immune-Related Toxicities in Melanoma

Dr. Luke on Current and Emerging Treatment Approaches in Metastatic Melanoma

Dr. Sznol on Managing Patients Beyond Initial Treatment in Melanoma

Dr. McQuade on Age as a Predictor of Response to Neoadjuvant Immunotherapy in Melanoma

Dr. Marron on Shortening Treatment Duration of Immunotherapy in Melanoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Checkpoint Inhibitors in Second and Third-line

Unmet Needs and Future Treatments of Metastatic Melanoma

The Use of Dual Targeted Therapy in Metastatic Melanoma

$Management of Relapsed/Refractory Metastatic Melanoma$

Immunotherapy vs TKIs in BRAF+ Metastatic Melanoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Novel Therapies for BRAF+ Colorectal Cancer

Treating BRAF+ Colorectal Cancer

Targeting BRAF and MEK in Colorectal Cancer

Emerging Treatment Strategies for Advanced BRAF+ Melanoma

Sequencing Therapy in Metastatic BRAF+ Melanoma

Selecting Therapy & Managing Patients With BRAF+ Melanoma

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Metastatic Melanoma: The New Millennium

Keith Flaherty, MD, moderates this discussion with Rene Gonzalez, MD, Jason Luke, MD, FACP, and Jeffrey Weber, MD, PhD. The panel of experts in melanoma research and treatment talk about the most recent advances in the field, and provide perspective on how to apply the newest data to individualize treatment strategies.

View Now

Dr. Hodi on Long-Term Survival Data for Nivolumab in Melanoma

F. Stephen Hodi, MD, director of the Melanoma Center at Dana-Farber Cancer Institute, and investigator at the Ludwig Center at Harvard, discusses the results of a 5-year follow-up analysis of survival outcomes of patients with advanced melanoma who were treated with single-agent nivolumab (Opdivo).

View Now

Featured Video

Dr. Esteva on the Future of Biosimilars in Breast Cancer

Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now

FDA Approvals in Urothelial Cancer and GIST, Promising Data in Urothelial Carcinoma, and More